I'm going to repeat myself.
BOTTOM LINE:
AXIM and MJNA insiders have control over ALL the AXIM assets. Verséa Ophthalmics is building their business on the foundation of the exclusive marketing agreement for three of the AXIM Dry Eye Disease Tear based Point-of-Care tests.
MY OPINION:
Personally I have been a "big" buyer below a penny in the last month or two. This is not investment advice. Penny stocks can have a high level of volatility. There is a risk of losing everything invested in AXIM. Don't invest money needed for food or rent or happiness.
STANDING ON A LIMB OPINIONS:
If my analytical brain studies the two paragraphs above I arrive at the following conclusion.
First, AXIM is out of cash and possibly getting closer to running out of insider credit. AXIM & MJNA still control 100% of the AXIM assets. Someone with deep pockets allows the party to continue. When will the credit cards be cut in half?
Second, we know Verséa Ophthalmics has an exclusive merchandising agreement with AXIM for three AXIM tests, 2 of which are FDA cleared.
In my opinion, it makes a lot of sense for Verséa Ophthalmics to have more control over their own future. That would imply shared ownership over the assets controlled by a financially struggling AXIM. Based on nothing but opinion, I believe some form of merger is in progress behind the scenes. Possibly a stock for stock (no cash) merger that allows all parties to retain ownership but also allows Verséa Health shared ownership over the AXIM portfolio of products. In this scenario everyone wins including retail investors. Verséa Health can IPO the consolidation and raise needed money for the combined business.
Maybe farfetched. 100% opinion.
My theory is based on an analytical exercise focused on the needs and assets of the two companies joined by the marketing agreement. On paper it could work out for everyone if a merger can agree on the value of each business.
Hope this limb doesn't break.
Not investment advice.
